POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESSING THE OUTCOME OF PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA ENROLLED IN THE FOLL05 TRIAL BY FIL. (June 2017) - Luminari, S.; Marcheselli, L.; Manni, M.; Anastasia, A.; Vitolo, U.; Chiarenza, A.; Rigacci, L.; Angelucci, E.; Fama, A.; Pulsoni, A.; Rattotti, S.; Angrilli, F.; et al.